Evidence map›Paper›PMID 34419237›Full record

ArticleThe Lancet. Global health2021

Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study.

Emmy Okello, Emma Ndagire, Babu Muhamed, Rachel Sarnacki, Meghna Murali, Jafesi Pulle, Jenifer Atala, Asha C Bowen, Marc P DiFazio, M G Nakitto and 18 more

Open access · goldAbstract readComment
In one paragraph

Article in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Acute rheumatic fever and rheumatic heart disease.Nature reviews. Disease primers · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Rheumatic Heart Disease in the Developing World.Structural heart : the journal of the Heart Team · 2023
    Review
  14. Review
  15. Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 3 countries.

Emmy OkelloThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda; Department of Medicine, Makerere University, Kampala, Uganda.
Emma NdagireThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Babu MuhamedMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Rachel SarnackiMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Meghna MuraliMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Jafesi PulleThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Jenifer AtalaThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Asha C BowenWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, and Department of Infectious Diseases, Perth Children's Hospital, Nedlands, WA, Australia.
Marc P DiFazioMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
M G NakittoThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Nada S HarikMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Rosemary KansiimeThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Chris T LongeneckerCase Western Reserve University, Health Education Campus, Cleveland, OH, USA.
Peter LwabiThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Collins AgabaThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Scott A NortonDepartment of Dermatology, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Isaac Otim OmaraThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Linda Mary OyellaThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Tom ParksWellcome Center for Human Genetics, The London School of Tropical Medicine and Hygiene, London, UK.
Joselyn RwebemberaThe Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda.
Christopher F SpurneyMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Elizabeth SteinUniversity of Washington School of Medicine, Seattle, WA, USA.
Laura TochenMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
David WatkinsDepartment of Medicine and Department of Global Health, University of Washington, Seattle, WA, USA.
Meghan ZimmermanDartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Jonathan R CarapetisWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, and Department of Infectious Diseases, Perth Children's Hospital, Nedlands, WA, Australia.
Craig A SableMakerere School of Health Sciences, Children's National Hospital, Washington DC, USA.
Andrea BeatonCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; The University of Cincinnati School of Medicine, Cincinnati, OH, USA. Electronic address: andrea.beaton@cchmc.org.
Mulago Hospital · UGChildren's National · USThe Kids Research Institute Australia · AUUniversity of Washington · USCase Western Reserve University · USCincinnati Children's Hospital Medical Center · USDartmouth–Hitchcock Medical Center · USGeorge Washington University · US

Funding

American Heart Association-American Stroke Association 17SFRN33670607NHLBI NIH HHS L40 HL124634
6 · The paper itself

Abstract

backgroundAcute rheumatic fever is infrequently diagnosed in sub-Saharan African countries despite the high prevalence of rheumatic heart disease. We aimed to determine the incidence of acute rheumatic fever in northern and western Uganda.

methodsFor our prospective epidemiological study, we established acute rheumatic fever clinics at two regional hospitals in the north (Lira district) and west (Mbarara district) of Uganda and instituted a comprehensive acute rheumatic fever health messaging campaign. Communities and health-care workers were encouraged to refer children aged 3-17 years, with suspected acute rheumatic fever, for a definitive diagnosis using the Jones Criteria. Children were referred if they presented with any of the following: (1) history of fever within the past 48 h in combination with any joint complaint, (2) suspicion of acute rheumatic carditis, or (3) suspicion of chorea. We excluded children with a confirmed alternative diagnosis. We estimated incidence rates among children aged 5-14 years and characterised clinical features of definite and possible acute rheumatic fever cases.

findingsData were collected between Jan 17, 2018, and Dec 30, 2018, in Lira district and between June 5, 2019, and Feb 28, 2020, in Mbarara district. Of 1075 children referred for evaluation, 410 (38%) met the inclusion criteria; of these, 90 (22%) had definite acute rheumatic fever, 82 (20·0%) had possible acute rheumatic fever, and 24 (6%) had rheumatic heart disease without evidence of acute rheumatic fever. Additionally, 108 (26%) children had confirmed alternative diagnoses and 106 (26%) had an unknown alternative diagnosis. We estimated the incidence of definite acute rheumatic fever among children aged 5-14 years as 25 cases (95% CI 13·7-30·3) per 100 000 person-years in Lira district (north) and 13 cases (7·1-21·0) per 100 000 person-years in Mbarara district (west).

interpretationTo the best of our knowledge, this is the first population-based study to estimate the incidence of acute rheumatic fever in sub-Saharan Africa. Given the known rheumatic heart disease burden, it is likely that only a proportion of children with acute rheumatic fever were diagnosed. These data dispel the long-held hypothesis that the condition does not exist in sub-Saharan Africa and compel investment in improving prevention, recognition, and diagnosis of acute rheumatic fever.

fundingAmerican Heart Association Children's Strategically Focused Research Network Grant, THRiVE-2, General Electric, and Cincinnati Children's Heart Institute Research Core.

Indexed as

Rheumatic FeverRheumatic Heart DiseaseHumansIncidenceProspective StudiesUganda

Identifiers

PMID34419237
PMCPMC11144057
OpenAlexW3195150560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.